ORHub, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ORHB research report →
Price Chart
About the company
ORHub, Inc. provides surgical software focusing on real-time surgical data analytics. The company's suite of products serves the needs of the health care industry, hospitals, patients, the government, and medical device vendors.
- CEO
- Christopher Wiggins
- IPO
- 2009
- Employees
- 72
- HQ
- Phoenix, AZ, US
Get TickerSpark's AI analysis on ORHB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $27.50K
- P/E
- -0.01
- PEG
- -0.00
- P/S
- 0.08
- P/B
- -0.02
- EV/EBITDA
- -0.70
- Div Yield
- 0.00%
- Gross Margin
- 68.61%
- Op Margin
- -3742.84%
- Net Margin
- -4120.42%
- ROE
- 170.02%
- ROIC
- 1341.80%
Latest fiscal year · YoY change
- Revenue
- $324.87K+116.6%
- Gross Profit
- $222.90K+57.3%
- Op Income
- $-12,159,341
- Net Income
- $-13,385,957-164.4%
- EPS
- $-0.02-39.4%
- OCF Growth
- +49.8%
- FCF Growth
- +49.8%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.07
- RSI (14)
- 44
- Avg Volume
- 12.06K
No earnings-call transcripts are available for ORHB yet.
- Free Float
- 0.0%
- Shares Outstanding
- 137.50M
- Float Shares
- 0
Our ORHB coverage
Recent articles, reports, and earnings notes.
No research on ORHB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ORHB report →Hippofi Welcomes Scott Bauccio as New Head of Sales for Pur Biologics
accesswire.com · Jan 23
HippoFi Ships International Orders and Expects Sales to Exceed $20 Million in the New Year
accesswire.com · Dec 11
HippoFi Continues to Deliver Sales Growth Adding 14 Major Healthcare Facilities
accesswire.com · Dec 5
Dr. Gail Naughton, World-Renowned Authority in the Multibillion-Dollar Regenerative Medicine Market, Joins HippoFi as the Head of Regenerative Therapeutics and Commercialization
accesswire.com · Nov 7
International Sales Win for PUR Biologics
accesswire.com · Oct 24
PUR Biologics Secures Innovative Medical Patent with Strong Financial Upside
accesswire.com · Sep 12
HippoFi Announces Strategic Alliance to Lead Spinal Biologics Innovation
accesswire.com · Sep 6
HippoFi To Announce Strategic Alliance With Orthopedic Industry Leader
accesswire.com · Sep 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.